This article presents a general strategy for authorship of deviation investigations, with primary focus on regulatory inspection success.
Pawel Drapala
Advertisement
Pawel Drapala, PhD, is an associate director, development and operations at Tesaro, Inc.
Articles by Pawel Drapala
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Choosing a Connected Product Technology for Anticounterfeiting
5